Fsd Pharma Class Stock Return On Asset
HUGEDelisted Stock | USD 0.09 0 4.56% |
FSD Pharma Class fundamentals help investors to digest information that contributes to FSD Pharma's financial success or failures. It also enables traders to predict the movement of FSD Stock. The fundamental analysis module provides a way to measure FSD Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to FSD Pharma stock.
FSD |
FSD Pharma Class Company Return On Asset Analysis
FSD Pharma's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current FSD Pharma Return On Asset | -0.34 |
Most of FSD Pharma's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, FSD Pharma Class is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, FSD Pharma Class has a Return On Asset of -0.3374. This is 96.14% lower than that of the IT Services sector and significantly lower than that of the Information Technology industry. The return on asset for all United States stocks is 141.0% higher than that of the company.
FSD Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses FSD Pharma's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of FSD Pharma could also be used in its relative valuation, which is a method of valuing FSD Pharma by comparing valuation metrics of similar companies.FSD Pharma is currently under evaluation in return on asset category among its peers.
FSD Fundamentals
Return On Equity | -0.64 | |||
Return On Asset | -0.34 | |||
Current Valuation | 4.57 M | |||
Shares Outstanding | 46.06 M | |||
Shares Owned By Insiders | 9.74 % | |||
Shares Owned By Institutions | 2.81 % | |||
Number Of Shares Shorted | 176.97 K | |||
Price To Earning | (1.53) X | |||
Price To Book | 0.50 X | |||
Price To Sales | 91.86 X | |||
Gross Profit | (3.33 M) | |||
EBITDA | (17.38 M) | |||
Net Income | (18.56 M) | |||
Cash And Equivalents | 31.62 M | |||
Cash Per Share | 0.83 X | |||
Total Debt | 337.46 K | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 3.98 X | |||
Book Value Per Share | 0.30 X | |||
Cash Flow From Operations | (11.03 M) | |||
Short Ratio | 0.11 X | |||
Earnings Per Share | (0.25) X | |||
Target Price | 2.6 | |||
Number Of Employees | 10 | |||
Beta | 0.85 | |||
Market Capitalization | 4.65 M | |||
Total Asset | 17.39 M | |||
Retained Earnings | (157.1 M) | |||
Working Capital | 6.52 M | |||
Current Asset | 3 M | |||
Current Liabilities | 13 M | |||
Net Asset | 17.39 M |
About FSD Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze FSD Pharma Class's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of FSD Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of FSD Pharma Class based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Consideration for investing in FSD Stock
If you are still planning to invest in FSD Pharma Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the FSD Pharma's history and understand the potential risks before investing.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |